How FDA assigns drug-device, biologic-device, and drug-biologic combination products to CDER, CBER, or CDRH: primary mode of action, the Request for Designation process, and how sponsors should plan around jurisdiction early.

Breakthrough Device Designation by the numbers: how many designations FDA has granted, how few have reached marketing authorization, and what the program actually changes for sponsors beyond the headline.